• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Marijuana Stock Movers For June 14, 2024

    6/14/24 4:30:05 PM ET
    $CARA
    $CRBP
    $ESE
    $GNLN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CARA alert in real time by email

    GAINERS:

    • Global Hemp Group (OTC:GBHPF) shares closed up 74.00% at $0.05
    • Elixinol Wellness (OTC:ELLXF) shares closed up 57.69% at $0.00
    • AusCann Group Holdings (OTC:ACNNF) shares closed up 45.00% at $0.01
    • Global Compliance (OTC:FUAPF) shares closed up 37.67% at $0.01
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed up 27.03% at $0.01
    • Heritage Cannabis Holding (OTC:HERTF) shares closed up 26.08% at $0.00
    • 22nd Century Group (NASDAQ:XXII) shares closed up 10.56% at $0.81
    • Target Group (OTC:CBDY) shares closed up 9.09% at $0.00
    • Psychemedics (NASDAQ:PMD) shares closed up 9.09% at $2.25
    • Greenlane Hldgs (NASDAQ:GNLN) shares closed up 7.76% at $0.51
    • 4Front Ventures (OTC:FFNTF) shares closed up 7.10% at $0.09
    • Nextleaf Solutions (OTC:OILFF) shares closed up 4.17% at $0.07
    • Leafbuyer Techs (OTC:LBUY) shares closed up 3.42% at $0.02

    LOSERS:

    • Maple Leaf Green World (OTC:MGWFF) shares closed down 27.40% at $0.02
    • CordovaCann (OTC:LVRLF) shares closed down 23.92% at $0.06
    • Cara Therapeutics (NASDAQ:CARA) shares closed down 21.10% at $0.35
    • SOL Glb Inv (OTC:SOLCF) shares closed down 19.08% at $0.05
    • Rocky Mountain High (OTC:RMHB) shares closed down 11.55% at $0.01
    • Blueberries Medical (OTC:BBRRF) shares closed down 10.07% at $0.01
    • Body and Mind (OTC:BMMJ) shares closed down 7.52% at $0.04
    • Zoned Props (OTC:ZDPY) shares closed down 5.86% at $0.61
    • Mexco Energy (AMEX:MXC) shares closed down 5.34% at $11.10
    • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed down 5.28% at $50.10
    • Trulieve Cannabis (OTC:TCNNF) shares closed down 4.97% at $8.50
    • MariMed (OTC:MRMD) shares closed down 4.86% at $0.19
    • Emeren Group (NYSE:SOL) shares closed down 4.73% at $1.63
    • GrowGeneration (NASDAQ:GRWG) shares closed down 4.31% at $2.42
    • Cresco Labs (OTC:CRLBF) shares closed down 3.85% at $1.62
    • Curaleaf Holdings (OTC:CURLF) shares closed down 3.82% at $4.01
    • Auxly Cannabis Group (OTC:CBWTF) shares closed down 3.50% at $0.02
    • ESCO Technologies (NYSE:ESE) shares closed down 3.36% at $104.05

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $CRBP
    $ESE
    $GNLN

    CompanyDatePrice TargetRatingAnalyst
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2025$28.00Buy
    B. Riley Securities
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    2/28/2025Outperform
    William Blair
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    12/2/2024Overweight
    Piper Sandler
    ESCO Technologies Inc.
    $ESE
    10/21/2024$150.00Buy
    The Benchmark Company
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2024$85.00Outperform
    Wedbush
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/22/2024$80.00Buy
    H.C. Wainwright
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    6/26/2024$85.00Buy
    B. Riley Securities
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    More analyst ratings

    $CARA
    $CRBP
    $ESE
    $GNLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ESCO Reports First Quarter Fiscal 2026 Results

    St. Louis, Feb. 05, 2026 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE:ESE) (ESCO, or the Company) today reported its operating results for the first quarter ended December 31, 2025 (Q1 2026).     Operating Highlights Q1 2026 Sales increased $75 million (35.0 percent) to $290 million compared to $215 million in Q1 2025. Q1 2026 organic sales increased $24 million (11.4 percent) and Maritime contributed $51 million (23.6 percent) of revenue growth in the quarter.Q1 2026 GAAP EPS from Continuing Operations increased 40.5 percent to $1.11 per share compared to $0.79 per share in Q1 2025. Q1 2026 Adjusted EPS from Continuing Operations increased 72.6 percent to $1.64 per share compared to

    2/5/26 4:15:00 PM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    GrowGeneration Showcases New Strategic Co-Marketing and Sales Collaboration with Netafim at Indoor Ag-Con 2026

    DENVER, Feb. 04, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGen" or the "Company"), one of the nation's largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced that it will host an exhibit at the Indoor Ag-Con 2026 Conference, taking place February 11–12, 2026, in Las Vegas, Nevada. Details are included below: Indoor Ag-Con 2026Date: February 11–12, 2026Location: Westgate Las Vegas Resort & Casino – Las Vegas, NVBooth: 902Attendees: Jason Holland, VP of Product Innovation & Commercial Solutions; Steve Sevener, Viagrow Founder & VP of Lawn & Garden; Brandon Collins, Com

    2/4/26 8:00:00 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $CARA
    $CRBP
    $ESE
    $GNLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities resumed coverage on Corbus Pharma with a new price target

    B. Riley Securities resumed coverage of Corbus Pharma with a rating of Buy and set a new price target of $28.00

    7/30/25 8:22:15 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on Corbus Pharma

    William Blair initiated coverage of Corbus Pharma with a rating of Outperform

    2/28/25 7:22:12 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Piper Sandler initiated coverage on Corbus Pharma

    Piper Sandler initiated coverage of Corbus Pharma with a rating of Overweight

    12/2/24 9:55:40 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $ESE
    $GNLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    President Salaman Michael bought $103,413 worth of shares (85,465 units at $1.21), increasing direct ownership by 6% to 1,639,313 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:41 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    CEO Lampert Darren bought $98,340 worth of shares (82,639 units at $1.19), increasing direct ownership by 5% to 1,728,522 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:01 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $CARA
    $CRBP
    $ESE
    $GNLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Valdez Gloria L exercised 1,349 shares at a strike of $238.40, increasing direct ownership by 63% to 3,480 units (SEC Form 4)

    4 - ESCO TECHNOLOGIES INC (0000866706) (Issuer)

    2/6/26 10:58:20 AM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    Director Phillippy Robert J exercised 1,349 shares at a strike of $238.40, increasing direct ownership by 21% to 7,868 units (SEC Form 4)

    4 - ESCO TECHNOLOGIES INC (0000866706) (Issuer)

    2/6/26 10:57:07 AM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    Director Khilnani Vinod M exercised 1,349 shares at a strike of $238.40, increasing direct ownership by 7% to 21,817 units (SEC Form 4)

    4 - ESCO TECHNOLOGIES INC (0000866706) (Issuer)

    2/6/26 10:55:57 AM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    $CARA
    $CRBP
    $ESE
    $GNLN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $ESE
    $GNLN
    SEC Filings

    View All

    Greenlane Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Greenlane Holdings, Inc. (0001743745) (Filer)

    2/9/26 5:21:11 PM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    SEC Form 10-Q filed by ESCO Technologies Inc.

    10-Q - ESCO TECHNOLOGIES INC (0000866706) (Filer)

    2/9/26 12:33:11 PM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    ESCO Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - ESCO TECHNOLOGIES INC (0000866706) (Filer)

    2/5/26 4:15:49 PM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    $CARA
    $CRBP
    $ESE
    $GNLN
    Financials

    Live finance-specific insights

    View All

    ESCO Reports First Quarter Fiscal 2026 Results

    St. Louis, Feb. 05, 2026 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE:ESE) (ESCO, or the Company) today reported its operating results for the first quarter ended December 31, 2025 (Q1 2026).     Operating Highlights Q1 2026 Sales increased $75 million (35.0 percent) to $290 million compared to $215 million in Q1 2025. Q1 2026 organic sales increased $24 million (11.4 percent) and Maritime contributed $51 million (23.6 percent) of revenue growth in the quarter.Q1 2026 GAAP EPS from Continuing Operations increased 40.5 percent to $1.11 per share compared to $0.79 per share in Q1 2025. Q1 2026 Adjusted EPS from Continuing Operations increased 72.6 percent to $1.64 per share compared to

    2/5/26 4:15:00 PM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    ESCO Technologies Announces First Quarter 2026 Earnings Release and Conference Call

    St. Louis, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE:ESE) will report its first quarter financial results after the market close on Thursday, February 5, 2026, followed by a conference call where the financial results and related commentary will be discussed.   Event:       First Quarter 2026 Conference Call Date:        Thursday, February 5Time:        4:00 p.m. Central Time The conference call webcast and an accompanying slide presentation will be available in the Investor Center of ESCO's website. The slide presentation will be utilized during the call and will be posted on the website prior to the call. Participants may also access the webcast using this registra

    1/14/26 4:15:00 PM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    $CARA
    $CRBP
    $ESE
    $GNLN
    Leadership Updates

    Live Leadership Updates

    View All

    22nd Century Announces First Shipments of Pinnacle VLN® Products to Top 5 C-Store Chain Locations Across 12 States

    Pinnacle VLN® from 22nd Century Gains 2nd Early Adopter to Join Popular Pinnacle Branded Conventional Cigarette Products Already Sold at Top-5 U.S. C-Store Chain MOCKSVILLE, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced the first shipments of its new Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine content cigarettes into distribution. These initial Pinnacle VLN® shipments will support a sales launch expected on September 1, 2025 at almost 1,000 locations across 12 states for a

    8/4/25 8:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Emeren Group Announces North America Management Change and Preliminary Q2 2025 Operating Results

    NORWALK, Conn., July 3, 2025 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE:SOL), a leading global solar project developer, owner, and operator, today announced a leadership transition within its North America operations. Mr. Cameron "Mac" Moore, Executive Vice President - North America, has departed the Company, and Mr. M. Jahangir Alam has been appointed as his successor, effective immediately. About M. Jahangir Alam M. Jahangir Alam is a seasoned leader in the North American renewable energy industry, with nearly three decades of experie

    7/3/25 4:30:00 PM ET
    $SOL
    Semiconductors
    Technology

    Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

    NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of Rachelle Jacques as Chair of its Board of Directors, effective May 15. She succeeds Alan Holmer, who will remain on the Board. "We thank Alan for his over ten years of dedicated service as founding Chair of the Corbus Board," said Yuval Cohen, Ph.D., Chief Executive Officer of Corbus. "Rachelle is a seasoned biopharmaceutical executive, and we have greatly benefitted from her innovative and strategic thinking as a Board member.  We look forward to following her vision and continued leadership as we

    5/19/25 8:00:00 AM ET
    $AKTX
    $CRBP
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $ESE
    $GNLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/5/24 6:04:48 PM ET
    $PMD
    Medical Specialities
    Health Care